Samson Jolly

Samson Jolly is a physician scientist specializing in translational medicine, focusing on the application of research to improve human health. Jolly holds an MD/PhD from the University of Massachusetts Medical School and a Master's degree in Organic Chemistry from Temple University. With experience as a medical student and internal medicine resident, Jolly is currently involved as a sub-investigator in a clinical trial studying the impacts of siRNA inclisiran. Prior to these roles, Jolly worked as a medicinal chemist at Merck, contributing to the development of FDA-approved drugs and conducting significant research in antiviral therapies.